Latest news
02-12-2021 - MRC Launches Cell and Oligonucleotide Therapy Fellowship with AstraZeneca
Funding for clinical and non-clinical postdoctoral researchers to conduct a fellowship in cell and oligonucleotide therapies.
The Medical Research Council (MRC) has launched an opportunity in partnership with AstraZeneca to enable clinical and non-clinical postdoctoral researchers to conduct a fellowship in cell and oligonucleotide therapies. Fellows will have the opportunity to explore their own research ideas and develop links with industry, through secondments, training and mentorship opportunities.
[...]